The newspapers El Punt AVUI and Diari de Girona have interviewed Manuel Serrano, ICREA researcher and head of the Cell Plasticity and Disease Laboratory at IRB Barcelona, about the current projects underway in his group. In Serrano’s words, this laboratory “is working on finding new compounds—experimental drugs—that kill these cells (senescent cells)". The objective of this research is to understand why aging happens.
link to: Diari de Girona
link to: El Punt AVUI
link to: TV Girona
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to offer pioneering solutions to unresolved medical needs in cancer and other diseases related to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).